Eiry Roberts's Net Worth

$15.9 Million

Estimate Recalculated Nov 8, 2024 09:35PM EST

Who is Eiry Roberts

Eiry Roberts has an estimated net worth of $15.9 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, and AMICUS THERAPEUTICS, INC..

SEC CIK

Eiry Roberts's CIK is 0001727606

Past Insider Trading and Trends

2023 was Eiry Roberts's most active year for acquiring shares with 13 total transactions. Eiry Roberts's most active month to acquire stocks was the month of January. 2023 was Eiry Roberts's most active year for disposing of shares, totalling 26 transactions. Eiry Roberts's most active month to dispose stocks was the month of November. 2023 saw Eiry Roberts paying a total of $7,882,349.40 for 200,043 shares, this is the most they've acquired in one year. In 2023 Eiry Roberts cashed out on 245,580 shares for a total of $24,874,574.75, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEUROCRINE BIOSCIENCES INC

Chief Medical Officer
Updated Feb 15, 2024
Form 4
104.30%
25.90K
$132.96
-$148.12K
Feb 15, 2024
50.73K
Grant
ScheduledFeb 13
Form 4
-4.50%
-2.10K
$138.23
-$290.97K
Feb 08, 2024
44.55K
Sale
ScheduledFeb 06 - Feb 08
Form 4
-6.54%
-1.46K
$140.79
-$205.13K
Feb 02, 2024
20.83K
Sale
ScheduledJan 31
Form 4
-33.87%
-10.00K
$126.74
-$1.27M
Dec 27, 2023
19.52K
Sale
ScheduledDec 22
Form 4
-10.77%
-13.93K
$90.87
-$1.68M
Dec 14, 2023
115.35K
Sale
ScheduledDec 12
Form 4
-28.35%
-77.68K
$89.59
-$9.35M
Dec 11, 2023
196.36K
Sale
ScheduledDec 07 - Dec 08
Form 4
-9.39%
-8.40K
$88.37
-$1.01M
Dec 08, 2023
80.99K
Sale
ScheduledDec 06
Form 4
-9.77%
-3.20K
$107.38
-$343.39K
Aug 23, 2023
29.52K
Sale
Aug 21
Form 4
-35.08%
-14.40K
$103.48
-$1.49M
Apr 26, 2023
26.64K
Sale
Apr 24
Form 4/A
Apr 26, 2023
13.51K
Form 4
60.98K
Feb 15, 2023
60.99K
Grant
Feb 13
Form 4
-10.77%
-16.52K
$103.68
-$1.70M
Feb 08, 2023
136.96K
Sale
ScheduledFeb 06 - Feb 08
Form 4
-5.27%
-1.46K
$109.99
-$160.25K
Feb 02, 2023
26.17K
Sale
ScheduledJan 31
Form 4
-4.98%
-3.72K
$80.36
-$299.59K
Feb 09, 2022
71.11K
Sale
ScheduledFeb 07 - Feb 08
Form 4
86.48K
Feb 02, 2022
86.49K
Grant
Jan 31
Form 4
-11.01%
-2.63K
$74.50
-$196.09K
Jan 12, 2022
21.28K
Sale
ScheduledJan 10
Form 4/A
49.05K
Mar 29, 2021
49.05K
Grant
Feb 08
Form 4
129.83%
49.71K
$116.75
-$275.94K
Feb 09, 2021
88.00K
Grant
ScheduledFeb 08
Form 4
-14.24%
-2.63K
$111.06
-$292.30K
Jan 12, 2021
15.85K
Sale
ScheduledJan 08
Form 4
-14.34%
-2.26K
$90.74
-$204.81K
Nov 16, 2020
13.48K
Sale
ScheduledNov 12
Form 4
-16.47%
-2.26K
$118.84
-$268.23K
Aug 07, 2020
11.45K
Sale
ScheduledAug 05
Form 4
-6.73%
-5.00K
$90.86
-$650.00K
Jun 25, 2020
69.28K
Sale
ScheduledJun 23
Form 4
-17.04%
-1.93K
$99.47
-$192.38K
Apr 28, 2020
9.42K
Sale
ScheduledApr 24
Form 4
-17.88%
-1.62K
$103.31
-$167.68K
Feb 11, 2020
7.45K
Sale
ScheduledFeb 07
Form 4
62.18K
Feb 07, 2020
62.18K
Grant
Feb 06
Form 4
-30.52%
-2.63K
$111.11
-$292.44K
Jan 10, 2020
5.99K
Sale
ScheduledJan 08
Form 4
79.01K
Feb 08, 2019
79.01K
Grant
Feb 07
Form 4
-37.14%
-1.86K
$84.09
-$156.16K
Jan 10, 2019
3.14K
Sale
ScheduledJan 08
Form 4
30.65K
Feb 07, 2018
30.65K
Grant
Feb 05
Form 4
90.00K
Jan 10, 2018
90.00K
Grant
Jan 08
Form 3
Jan 10, 2018
Showing 31 results

AMICUS THERAPEUTICS, INC.

Investor
Updated Jun 07, 2024
Form 4
123.40%
54.31K
Jun 07, 2024
98.33K
Grant
Jun 06
Form 4
110.24%
39.06K
Jun 12, 2023
74.49K
Grant
Jun 08
Form 4
255.26%
58.09K
Jun 10, 2022
80.85K
Grant
Jun 09
Form 4
63.38K
Jun 14, 2021
63.38K
Grant
Jun 10
Form 3
Jun 14, 2021
Showing 5 results